Pando is an AI-driven synthetic biology company
Revolutionizing enzyme engineering for the pharmaceutical manufacturing and diagnostics industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our AI models to efficiently optimize enzymes across multiple properties, delivering high-performing, industrial-grade enzymes that create and capture new market value.
Customer Acquisition Overview in 2024
0
+
Companies
0
+
Projects
0
+
Recurring
The Problem
Enzymes are natural catalysts that accelerate chemical reactions. Inefficient enzymes result in substantial financial losses and missed market opportunities. Optimizing enzymes to balance key properties like manufacturability, stability, and activity is essential but challenging and time-consuming.
What We Offer
Unlocking the full potential of enzymes to drive down costs and boost productivity
PANDO
BIOSCIENCE